Cargando…
Thirty Years of Sweat Chloride Testing at One Referral Center
OBJECTIVE: To conduct a descriptive analysis of the sweat test (ST), associating ST results with epidemiological data, CFTR (cystic fibrosis transmembrane conductance regulator) mutations and reasons to indicate the ST, as well as correlating sweat sodium and sweat chloride concentrations in subject...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5662556/ https://www.ncbi.nlm.nih.gov/pubmed/29124052 http://dx.doi.org/10.3389/fped.2017.00222 |
_version_ | 1783274651920629760 |
---|---|
author | Faria, Alethéa Guimarães Marson, Fernando Augusto Lima Gomez, Carla Cristina Souza Servidoni, Maria de Fátima Ribeiro, Antônio Fernando Ribeiro, José Dirceu |
author_facet | Faria, Alethéa Guimarães Marson, Fernando Augusto Lima Gomez, Carla Cristina Souza Servidoni, Maria de Fátima Ribeiro, Antônio Fernando Ribeiro, José Dirceu |
author_sort | Faria, Alethéa Guimarães |
collection | PubMed |
description | OBJECTIVE: To conduct a descriptive analysis of the sweat test (ST), associating ST results with epidemiological data, CFTR (cystic fibrosis transmembrane conductance regulator) mutations and reasons to indicate the ST, as well as correlating sweat sodium and sweat chloride concentrations in subjects. METHODS: Retrospective survey and descriptive analysis of 5,721 ST at a university referral center. RESULTS: The inclusion of the subjects was based on clinical data related with cystic fibrosis (CF) phenotype. The samples were grouped by (i) sweat chloride concentrations (mEq/L): <30: 3,249/5,277 (61.6%); ≥30 to <60: 1,326/5,277 (25.1%); ≥60: 702/5,277 (13.3%) and (ii) age: (Group A––GA) 0 to <6 months; (Group B––GB) ≥6 months to <18 years; (Group C––GC) ≥18 years. Digestive symptoms showed higher prevalence ratio for the CF diagnosis as well as association between younger age and higher values of sweat chloride, sweat sodium, and chloride/sodium ratio. The indication of ST due to respiratory symptoms was higher in GB and associated with greater age, lower values of sweat chloride, sweat sodium, and chloride/sodium ratio. There was higher prevalence of ST with sweat chloride levels <30 mEq/L in GB, ≥60 mEq/L in GC, and with borderline level in GB. There was positive correlation between sweat sodium and sweat chloride. Sweat chloride/sweat sodium and sweat sodium–sweat chloride indexes showed association with sex, reason for ST indication, and CFTR mutations. Sex alters some values presented in the ST. The number of ST/year performed before and after the newborn screening implementation was the same; however, we observed a higher number of borderlines values. A wide spectrum of CFTR mutation was found. Severe CFTR mutations and F508del/F508del genotype were associated with highest probability of ST chloride levels ≥60 mEq/L, and the absence of CFTR mutations identified was associated with borderline ST and respiratory symptoms. CONCLUSIONS: ST data showed wide variability dependent on age, sex, reason for examination indication, CFTR mutations, and weight of the collected sweat sample. Sweat sodium concentration is directly correlated with sweat chloride levels and it could be used as a quality parameter. |
format | Online Article Text |
id | pubmed-5662556 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-56625562017-11-09 Thirty Years of Sweat Chloride Testing at One Referral Center Faria, Alethéa Guimarães Marson, Fernando Augusto Lima Gomez, Carla Cristina Souza Servidoni, Maria de Fátima Ribeiro, Antônio Fernando Ribeiro, José Dirceu Front Pediatr Pediatrics OBJECTIVE: To conduct a descriptive analysis of the sweat test (ST), associating ST results with epidemiological data, CFTR (cystic fibrosis transmembrane conductance regulator) mutations and reasons to indicate the ST, as well as correlating sweat sodium and sweat chloride concentrations in subjects. METHODS: Retrospective survey and descriptive analysis of 5,721 ST at a university referral center. RESULTS: The inclusion of the subjects was based on clinical data related with cystic fibrosis (CF) phenotype. The samples were grouped by (i) sweat chloride concentrations (mEq/L): <30: 3,249/5,277 (61.6%); ≥30 to <60: 1,326/5,277 (25.1%); ≥60: 702/5,277 (13.3%) and (ii) age: (Group A––GA) 0 to <6 months; (Group B––GB) ≥6 months to <18 years; (Group C––GC) ≥18 years. Digestive symptoms showed higher prevalence ratio for the CF diagnosis as well as association between younger age and higher values of sweat chloride, sweat sodium, and chloride/sodium ratio. The indication of ST due to respiratory symptoms was higher in GB and associated with greater age, lower values of sweat chloride, sweat sodium, and chloride/sodium ratio. There was higher prevalence of ST with sweat chloride levels <30 mEq/L in GB, ≥60 mEq/L in GC, and with borderline level in GB. There was positive correlation between sweat sodium and sweat chloride. Sweat chloride/sweat sodium and sweat sodium–sweat chloride indexes showed association with sex, reason for ST indication, and CFTR mutations. Sex alters some values presented in the ST. The number of ST/year performed before and after the newborn screening implementation was the same; however, we observed a higher number of borderlines values. A wide spectrum of CFTR mutation was found. Severe CFTR mutations and F508del/F508del genotype were associated with highest probability of ST chloride levels ≥60 mEq/L, and the absence of CFTR mutations identified was associated with borderline ST and respiratory symptoms. CONCLUSIONS: ST data showed wide variability dependent on age, sex, reason for examination indication, CFTR mutations, and weight of the collected sweat sample. Sweat sodium concentration is directly correlated with sweat chloride levels and it could be used as a quality parameter. Frontiers Media S.A. 2017-10-26 /pmc/articles/PMC5662556/ /pubmed/29124052 http://dx.doi.org/10.3389/fped.2017.00222 Text en Copyright © 2017 Faria, Marson, Gomez, Servidoni, Ribeiro and Ribeiro. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pediatrics Faria, Alethéa Guimarães Marson, Fernando Augusto Lima Gomez, Carla Cristina Souza Servidoni, Maria de Fátima Ribeiro, Antônio Fernando Ribeiro, José Dirceu Thirty Years of Sweat Chloride Testing at One Referral Center |
title | Thirty Years of Sweat Chloride Testing at One Referral Center |
title_full | Thirty Years of Sweat Chloride Testing at One Referral Center |
title_fullStr | Thirty Years of Sweat Chloride Testing at One Referral Center |
title_full_unstemmed | Thirty Years of Sweat Chloride Testing at One Referral Center |
title_short | Thirty Years of Sweat Chloride Testing at One Referral Center |
title_sort | thirty years of sweat chloride testing at one referral center |
topic | Pediatrics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5662556/ https://www.ncbi.nlm.nih.gov/pubmed/29124052 http://dx.doi.org/10.3389/fped.2017.00222 |
work_keys_str_mv | AT fariaaletheaguimaraes thirtyyearsofsweatchloridetestingatonereferralcenter AT marsonfernandoaugustolima thirtyyearsofsweatchloridetestingatonereferralcenter AT gomezcarlacristinasouza thirtyyearsofsweatchloridetestingatonereferralcenter AT servidonimariadefatima thirtyyearsofsweatchloridetestingatonereferralcenter AT ribeiroantoniofernando thirtyyearsofsweatchloridetestingatonereferralcenter AT ribeirojosedirceu thirtyyearsofsweatchloridetestingatonereferralcenter |